Remove topics patient-access
article thumbnail

Balancing Innovation: India’s Views for Pharmaceuticals in the Efta Trade Deal

IIPRD

The inclusion of TRIPS-plus provisions within trade agreements presents a potential challenge to global access to essential medicines. This price inflation can significantly hinder affordability and ultimately restrict access to life-saving medications. [vi] xiii] Ensuring access to affordable medications is a key priority for India.

article thumbnail

Understanding the Role of Preprints & Postprints & The Version of Record

Velocity of Content

As with my earlier post on the overall role of peer review in the scholarly and scientific publishing process, for Peer Review Week 2022 we are reposting this series and including some updated information on the topics we covered: An article in Nature Medicine suggests access to preprints might be good for patient outcomes.

Editing 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Who Spilled the (green) Beans? 11th Circuit Unseals Private Emails in Organ Transplant Dispute

LexBlog IP

The 11 th Circuit upheld a decision to unseal “embarrassing internal communications” between members of the United Network for Organ Sharing (“UNOS”) relating to its new policy directing liver transplants to go to the sickest patients within a certain radius of the donor.

article thumbnail

Book Review: ‘The Truth Pill: The Myth of Drug Regulation in India’

SpicyIP

It may, however, leave you feeling frightened, given the dysfunctional regulatory system in India and the impact this can have on patients around the world. Accessing information related to government agencies and departments is not easy and such opacity feeds into the failures of the regulatory system in general.

article thumbnail

ONC Information Blocking Data Show Majority of Claims Against Health Care Providers

LexBlog IP

ONC published data showing that 274 possible claims of information blocking have been received to date, with 176 claims submitted by a patient (directly or indirectly) and 42 by an attorney (the next largest category). ONC is now sharing preliminary data on the information blocking claims received for the first time.

Privacy 40
article thumbnail

ONC’s HTI-1 Final Rule Updates Information Blocking Regulations

LexBlog IP

Under the Final Rule, a new exception is added that applies when an actor will only fulfill requests for access, use, or exchange of EHI by way of the Trusted Exchange Framework and Common Agreement (TEFCA). Third and finally, certain consulting and legal services will be excluded from the definition of offer health IT.

article thumbnail

SpicyIP Weekly Review (August 9 – 15)

SpicyIP

Topical Highlight. Ensuring Access to TB drugs: Is Compulsory License the Way? In this post , Rahul Bajaj and Praharsh Gour analayse the underutilisation of Indian patent law’s robust flexibilities to promote patient interest. Thematic Highlight.